PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025

Rhea-AI Summary

PAVmed (Nasdaq: PAVM), a diversified commercial-stage medical technology company, has scheduled a business update conference call and webcast for August 14, 2025, at 8:30 AM ET. During the call, Chairman and CEO Dr. Lishan Aklog will discuss company operations and growth strategy, while President and CFO Dennis McGrath will present Q2 2025 financial results.

Investors can access the webcast through PAVmed's investor relations website. For telephone access, U.S. callers should dial 1-800-836-8184, while international callers can use 1-646-357-8785. A 30-day replay will be available on the company website following the call.

News Market Reaction

+1.71%

3 alerts

+1.71% News Effect

-13.9% Trough Tracked

+$171K Valuation Impact

$10M Market Cap

1.1x Rel. Volume

On the day this news was published, PAVM gained 1.71%, reflecting a mild positive market reaction. Argus tracked a trough of -13.9% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $171K to the company's valuation, bringing the market cap to $10M at that time.

Data tracked by StockTitan Argus on the day of publication.

Conference Call and Webcast at 8:30 AM Eastern Time

NEW YORK, July 31, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Thursday, August 14, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update including an overview of the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's second quarter 2025 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com. Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more and for more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-august-14-2025-302517035.html

SOURCE PAVmed Inc.

FAQ

When is PAVmed's (PAVM) Q2 2025 earnings call scheduled?

PAVmed's business update and earnings call is scheduled for August 14, 2025 at 8:30 AM ET.

How can investors access PAVmed's (PAVM) Q2 2025 earnings call?

Investors can access the call via webcast on PAVmed's investor relations website, or by phone: U.S. callers: 1-800-836-8184, International: 1-646-357-8785. Use conference name 'PAVmed Business Update'.

Who will be presenting at PAVmed's (PAVM) Q2 2025 earnings call?

Dr. Lishan Aklog (Chairman and CEO) will provide a business update and growth strategy overview, while Dennis McGrath (President and CFO) will discuss Q2 2025 financial results.

How long will the replay of PAVmed's (PAVM) Q2 2025 earnings call be available?

A replay of the conference call will be available for 30 days on PAVmed's investor relations website.